EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

N6 ‐Methyladenosine Demethylase FTO Mitigates Cerebral Ischemia–Reperfusion Injury by Suppressing AQP4 Expression

Wei Chen iD, Luyuan Cao, Xiaoxiao Zheng, Chenyuan Yu, Xiaoqiang Zhu, Qing Wang, Li Zheng, Jiahua Lan, Cheng Jiang iD, Hongwei Wang

CNS Neuroscience & Therapeutics · 2026-08 · 32 (8)

DOI: 10.1002/cns.71011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 04.08.2026. Verfasst von Wei Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Provincial Key Laboratory of Precise Diagnosis and Treatment of Abdominal Infection, Department of General Surgery, Sir Run Run Shaw Hospital, School…. Hauptthemen laut MEDLINE: Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Reperfusion Injury, Aquaporin 4, Brain Ischemia. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Medical Science and Technology Project of Zhejiang Province, National Natural Science Foundation of China-Guangdong Joint Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

In patients with acute ischemic stroke, reperfusion therapy can compromise the blood–brain barrier, resulting in secondary cerebral ischemia–reperfusion injury (CIRI). This study investigated the involvement of the N6‐methyladenosine (m6A) demethylase FTO in the pathogenesis of CIRI and explored the underlying molecular mechanisms.

Methods

We established a middle cerebral artery occlusion (MCAO) mouse model in vivo and an oxygen–glucose deprivation/reperfusion (OGD/R) model in primary astrocytes in vitro.

Results

FTO expression was significantly downregulated in both the in vivo and in vitro CIRI models. Upregulation of FTO via plasmid transfection significantly attenuated cellular damage and enhanced astrocyte viability. At the molecular level, m6A‐modified transcripts were enriched in the MAPK signaling pathway during cerebral ischemia–reperfusion. Notably, Heat Shock Protein Family A (Hsp70) Member 1A ( Hspa1a ) was identified as a key target. The reduction in FTO expression led to increased m6A methylation levels on Hspa1a mRNA, thereby promoting its degradation. Furthermore, the cellular damage induced by FTO silencing was alleviated by Hspa1a overexpression or the silencing of Aquaporin‐4 (AQP4).

Conclusions

This study demonstrates that FTO mitigates CIRI by stabilizing Hspa1a mRNA, which in turn suppresses AQP4 expression. Consequently, FTO represents a promising therapeutic target for the treatment of ischemic stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alpha-Ketoglutarate-Dependent Dioxygenase FTOReperfusion InjuryAquaporin 4Brain IschemiaAnimalsMaleMiceMice, Inbred C57BLAstrocytesInfarction, Middle Cerebral ArteryCells, CulturedAdenosine

Stichwörter der Autor:innen

Hspa1aAQP4FTOcerebral ischemia–reperfusion injurym6A modification

Substanzen

Alpha-Ketoglutarate-Dependent Dioxygenase FTOFTO protein, mouseAquaporin 4Aqp4 protein, mouseN-methyladenosineAdenosine

Autor:innen und Institutionen

  • Provincial Key Laboratory of Precise Diagnosis and Treatment of Abdominal Infection, Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • School of Basic Medical Sciences and Forensic Medicine, Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Cancer Institute of Integrated Traditional Chinese and Western Medicine, Key Laboratory of Cancer Prevention and Therapy Combining Traditional Chinese and Western Medicine of Zhejiang Province, Zhejiang Academy of Tradi…
  • Department of Anesthesiology, Tongde Hospital of Zhejiang Province, Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, China.

ORCID-Profile: Wei Chen, Cheng Jiang

Förderung

  • National Natural Science Foundation of China
  • Medical Science and Technology Project of Zhejiang Province
  • National Natural Science Foundation of China-Guangdong Joint Fund
  • the General Project of Science and Technology Innovation Commission of Shenzhen

Zitieren

APA

Chen, W., Cao, L., Zheng, X., Yu, C., Zhu, X., Wang, Q., Zheng, L., Lan, J., Jiang, C., & Wang, H. (2026). N6 ‐Methyladenosine Demethylase FTO Mitigates Cerebral Ischemia–Reperfusion Injury by Suppressing AQP4 Expression. CNS Neuroscience & Therapeutics, 32(8). https://doi.org/10.1002/cns.71011

Vancouver

Chen W, Cao L, Zheng X, Yu C, Zhu X, Wang Q, et al. N6 ‐Methyladenosine Demethylase FTO Mitigates Cerebral Ischemia–Reperfusion Injury by Suppressing AQP4 Expression. CNS Neuroscience & Therapeutics. 2026;32(8). doi:10.1002/cns.71011

BibTeX
@article{Chen2026,
  author = {Chen, Wei and Cao, Luyuan and Zheng, Xiaoxiao and Yu, Chenyuan and Zhu, Xiaoqiang and Wang, Qing and Zheng, Li and Lan, Jiahua and Jiang, Cheng and Wang, Hongwei},
  title = {N6 ‐Methyladenosine Demethylase FTO Mitigates Cerebral Ischemia–Reperfusion Injury by Suppressing AQP4 Expression},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  volume = {32},
  number = {8},
  doi = {10.1002/cns.71011}
}
Kostenlos starten →